摘要
目的观察泮托拉唑与血凝酶联合应用于上消化道出血治疗的临床效果。方法将在我院接受治疗的96例上消化道出血患者随机分为实验组(n=48)和对照组(n=48)。对照组予泮托拉唑治疗,实验组在对照组的基础上加用血凝酶治疗。比较两组患者的治疗总有效率、临床指标及不良反应发生率。结果实验组的治疗总有效率高于对照组(P <0.05);实验组有效止血时间和平均输血量/凝血酶原时间和活化部分凝血活酶时间均短/少于对照组(P <0.05);两组不良反应发生率差异无统计学意义(P> 0.05)。结论泮托拉唑联合血凝酶有利于提高上消化道出血患者临床疗效。
Objective To observe the clinical effect of pantoprazole combined with hemagglutinase in the treatment of upper gastrointestinal bleeding.Methods 96 patients with upper gastrointestinal hemorrhage who were treated in our hospital were randomLy divided into experimental group (n =48) and control group (n =48).The control group was treated with pantoprazole,and the experimental group was treated with hemagglutinase on the basis of the control group.The total effective rate of treatment,clinical indicators and incidence of adverse reactions were compared between the two groups.Results The total effective rate of treatment of the experimental group was better than that of the control group (P < 0.05).The effective hemostasis time and mean transfusion volume/prothrombin time and activated partial thromboplastin time in the experimental group were shorter/less than the control group (P < 0.05).There was no significant difference in the incidence of adverse reactions between the two groups (P > 0.05).Conclusion Pantoprazole combined with hemagglutinase is beneficial to improve the clinical efficacy of patients with upper gastrointestinal bleeding.
作者
郑啟晖
ZHENG Qihui(Department of Internal Medicine,Shanghai Hudong Hospital,Shanghai 200129,China)
出处
《中国卫生标准管理》
2019年第7期64-66,共3页
China Health Standard Management
关键词
泮托拉唑
血凝酶
上消化道出血
pantoprazole
hemagglutinase
upper gastrointestinal bleeding
